Blood Pressure Measurement Methods and Prediction of Intracranial Hemorrhage After Thrombectomy in Stroke

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

455 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-12-05

Study Completion Date

2024-12-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A monocentric, non-randomized, prospective study in which each patient is his/her own control.

The study investigates 2 methods of blood pressure measurement, within the first 24 hours after reperfusion, i) Continuous measurement of blood pressure with the Clearsight device (Edwards) and ii) intermittent blood pressure measurements with cuff.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Blood Pressure Target in Acute Stroke to Reduce hemorrhaGe After Endovascular Therapy

NCT03160677

Acute Stroke Blood Pressure Cerebral Hemorrhage

COMPLETED NA

TCD Detection of Ophthalmic Artery Blood Flow Velocity Prediction Feasibility Study of Intracranial Pressure

NCT02240394

Traumatic Brain Injury Cerebral Hemorrhage Increased Intracranial Pressure

UNKNOWN

Transcranial Doppler and Quantitative Pupillometry as Neurological Prognostic Factors in Brain Damaged Patients Admitted to Intensive Care Unit

NCT04846738

Brain Damage

COMPLETED

Effect of Individualized Versus Standard Bp Management During MT for Anterior Ischemic Stroke

NCT04352296

Acute Cerebrovascular Accident

COMPLETED NA

Tele-Stroke: Prehospital Identification of Patients With Suspected Stroke Using Onsite Mobile Telemedicine - Feasibility

NCT03370094

Stroke, Acute

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be followed for 72 hours:

* inclusion after reperfusion: clinical evaluation with NIHSS (National Institute of Health Stroke Score) score, measurement of blood pressure.
* within 24 hours after reperfusion: blood pressure measurements
* at 24 hours: NIHSS score.
* Between 24 and 36 hours :cerebral scan (assessment of hemorrhagic transformations and cerebral infarction volumes).
* 72 hours after reperfusion: brain scanner in case of hyperdensity on the initial scanner

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Stroke Blood Pressure Cerebral Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Two measuring methods of blood pressure

Clearsight device (Edwards) around the finger

Intervention Type DEVICE

Continuous measurement of blood pressure with the Clearsight device (Edwards) around the finger, within 24 hours after reperfusion:

Intermittent blood pressure measurements with cuff.

Intervention Type DEVICE

Standard method: 35 blood pressure measurements with cuff within 24 hours after reperfusion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clearsight device (Edwards) around the finger

Continuous measurement of blood pressure with the Clearsight device (Edwards) around the finger, within 24 hours after reperfusion:

Intervention Type DEVICE

Intermittent blood pressure measurements with cuff.

Standard method: 35 blood pressure measurements with cuff within 24 hours after reperfusion

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 18 years or older
* Treated for occlusion of the internal carotid arteries and/or proximal middle cerebral arteries (M1 and M2 segments), vertebral artery, and/or basilar artery
* Affiliated with or beneficiary of a Social Security plan
* Having received informed information about the study and having given consent to participate in the study

Exclusion Criteria

* Per-procedure hemorrhagic complications (before reperfusion is achieved)
* Patient benefiting from legal protection measures
* Pregnant or breastfeeding women

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No